Assessment of chronic myeloid leukemia patients' adherence with “tyrosine kinase inhibitors” in King Abdulaziz Medical City

Assessment of chronic myeloid leukemia patients' adherence with “tyrosine kinase inhibitors” in King Abdulaziz Medical City

CONTEXT: Worldwide, chronic myeloid leukemia (CML) accounts for 15% of all leukemia types. CML treatment and outcome has improved dramatically from the average survival of 3–5 years in the past to almost normal life expectancy with the new targeted therapy with tyrosine kinase inhibitors (TKI). Comp...

Full description

Bibliographic Details
Main Authors: Saad Saleh Aldughaythir, Yousef Alolah, Mohsen Alzahrani, Fahad Abdulaziz Alsayed, Bader Muaykil Alqahtani, Omar Abdulrahman Alhathlol
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Applied Hematology
Subjects:
Chronic myeloid leukemia
compliance
tyrosine kinase inhibitors
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2017;volume=8;issue=4;spage=140;epage=144;aulast=Aldughaythir

Internet

http://www.jahjournal.org/article.asp?issn=1658-5127;year=2017;volume=8;issue=4;spage=140;epage=144;aulast=Aldughaythir

Similar Items